In vitro studies showed that PROTAC 61 (LWY713) exhibited nanomolar degradation potency (DC50 = 0.64 nM, Dmax = 95%) in FLT3-ITD AML MV4-11 cells. The gene discussed is FLT3; the disease is acute myeloid leukemia.